Inpatient Glycemic Management of Non-cardiac CVD: Focus on Stroke and PVD

Everett, Estelle; Mathioudakis, Nestoras

doi:10.1007/s11892-018-1026-0

Cited by 4 publications

(1 citation statement)

References 65 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this study, magnetron sputtering technology was used to coat nano-Ti and nano-Ag on the diamondlike surface to prepare Ti/Ag-DLC composite diamond-like nano-membrane sensors. Diamond-like membranes could be prepared by many methods, which could be divided into two categories: Physical vapor deposition (PVD) and chemical vapor deposition (CVD) technologies (21). Magnetron sputtering technology was a kind of physical vapor deposition technology, which was widely used in the preparation of decorative coatings, protective coatings, optical coatings, and wear-resistant coatings (22).…”

Section: Preparation Of Composite Diamond-like Nanomembrane Sensorsmentioning

confidence: 99%

Effect of Acupuncture Treatment on Post-stroke Depression by Using Diamond-Like Ultra-Thin Nano-Coating Technology

Yang¹,

Cheng²,

Zhang³

et al. 2022

Cell Mol Biol (Noisy-le-grand)

View full text Add to dashboard Cite

This study aimed to explore the effect of acupuncture on account of composite diamond-like nanomembrane sensors (DLNF) sensors on post-stroke depression. Titanium/antigen-diamond-like carbon (Ti/Ag-DLC) composite DLNF sensors were prepared by coating Ti and Ag composites on the surface of DLC by radio frequency magnetron sputtering technology. The scanning electron microscope (SEM), X-ray photoelectron spectrometer (XPS), Raman spectrometer, nanoindenter, and sliding friction tester were adopted to analyze the characterization of Ti/Ag-DLC composite membrane, the chemical state of the main constituent elements on the surface, structural characteristics, membrane hardness, and tribological properties, respectively. 132 patients with post-stroke depression in our hospital were selected as the research objects, they were divided into the control group (receiving conventional treatment) and the acupuncture group (receiving acupuncture based on conventional treatment) according to different treatment methods, with 66 cases in each group. The depression of the two groups of patients before the treatment and 4 and 8 weeks after the treatment were compared. The psychological resilience scale and Herth scale were used to evaluate the mental toughness and hope level of patients. The results showed that when the Ag content was less than 0.55%, the Ti/Ag-DLC composite surface was smooth and showed no obvious particles, the membranes with different content had obvious absorption peaks at 1560 cm -1 and the friction life in a high vacuum environment was extended to around 900 revolutions. After 4 and 8 weeks of treatment, the scores of the hammer depression scale (HDS) in the two groups were significantly lower than before treatment (P<0.01) and the scores of the acupuncture group were much lower after 4 and 8 weeks of treatment in contrast to the control group (P<0.01). The optimism, self-strength, and tenacity in the psychological resilience scale of the acupuncture group patients rose higher than those in the control group (P<0.05) after 8 weeks of treatment. The Herth scale score of the acupuncture group was greatly higher compared with that of the control group after 8 weeks of treatment (P<0.01). It showed that the Ti/Ag-DLC composite DLNF sensor with good hardness and friction performance was prepared in this study. Acupuncture therapy could improve the negative emotions of patients with post-stroke depression, enhance mental resilience, and help raise the level of hope. Therefore, it was proved to be a potentially effective treatment.

show abstract

Section: Preparation Of Composite Diamond-like Nanomembrane Sensorsmentioning

confidence: 99%

Effect of Acupuncture Treatment on Post-stroke Depression by Using Diamond-Like Ultra-Thin Nano-Coating Technology

Yang¹,

Cheng²,

Zhang³

et al. 2022

Cell Mol Biol (Noisy-le-grand)

View full text Add to dashboard Cite

show abstract

Stratégies de prise en charge peropératoire de la glycémie : une étude de portée

Morin

Taylor

Krahn

et al. 2022

Can J Anesth/J Can Anesth

View full text Add to dashboard Cite

Insulin Therapy in Hospitalized Patients

Pérez

Ramos

Carreras

2020

American Journal of Therapeutics

View full text Add to dashboard Cite

Background: Hyperglycemia is prevalent and is associated with an increase in morbidity and mortality in hospitalized patients. Insulin therapy is the most appropriate method for controlling glycemia in hospital, but is associated with increased risk of hypoglycemia, which is a barrier to achieving glycemic goals. Areas of Uncertainty: Optimal glycemic targets have not been established in the critical and noncritical hospitalized patients, and there are different modalities of insulin therapy. The primary purpose of this review is to discuss controversy regarding appropriate glycemic targets and summarize the evidence about the safety and efficacy of insulin therapy in critical and noncritical care settings. Data Sources: A literature search was conducted through PubMed with the following key words (inpatient hyperglycemia, inpatient diabetes, glycemic control AND critically or non-critically ill patient, Insulin therapy in hospital). Results: In critically ill patient, blood glucose levels >180 mg/dL may increase the risk of hospital complications, and blood glucose levels <110 mg/dL have been associated with an increased risk of hypoglycemia. Continuous intravenous insulin infusion is the best method for achieving glycemic targets in the critically ill patient. The ideal glucose goals for noncritically ill patients remain undefined and must be individualized according to the characteristics of the patients. A basal-bolus insulin strategy resulted in better glycemic control than sliding scale insulin and lower risk of hypoglycemia than premixed insulin regimen. Conclusions: Extremes of blood glucose lead to poor outcomes, and target glucose range of 110–180 mg/dL may be appropriate for most critically ill patients and noncritically ill patients. Insulin is the most appropriate pharmacologic agent for effectively controlling glycemia in hospital. A continuous intravenous insulin infusion and scheduled basal-bolus-correction insulin are the preferred modalities for glycemic control in critically and noncritically ill hospitalized patients, respectively.

show abstract

Inpatient Glycemic Management of Non-cardiac CVD: Focus on Stroke and PVD

Cited by 4 publications

References 65 publications

Effect of Acupuncture Treatment on Post-stroke Depression by Using Diamond-Like Ultra-Thin Nano-Coating Technology

Effect of Acupuncture Treatment on Post-stroke Depression by Using Diamond-Like Ultra-Thin Nano-Coating Technology

Stratégies de prise en charge peropératoire de la glycémie : une étude de portée

Insulin Therapy in Hospitalized Patients

Contact Info

Product

Resources

About